Cargando…

Will all SARS-CoV-2 seroprevalence surveys provide the right picture?

Detalles Bibliográficos
Autores principales:	Valent, F., Gongolo, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society for Public Health. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373034/ https://www.ncbi.nlm.nih.gov/pubmed/32818725 http://dx.doi.org/10.1016/j.puhe.2020.07.020

Ejemplares similares

Potential drawbacks of SARS-CoV-2 seroprevalence surveys
por: Lippi, G.
Publicado: (2021)

SARS-CoV-2 seroprevalence in the Vatican City State
por: Ralli, Massimo, et al.
Publicado: (2021)

The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France
por: Dimeglio, Chloé, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
por: Martins-Filho, Paulo Ricardo, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in low-income university students
por: Araújo, Adriano Antunes de Souza, et al.
Publicado: (2021)

High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients
por: ABDI, Basma, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
por: Eisenhut, Katharina, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in 2115 blood donors from Romania
por: Olariu, Tudor Rares, et al.
Publicado: (2021)

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland
por: Ahava, Maarit J., et al.
Publicado: (2022)

Seroprevalence of SARS-Cov-2 in 646 professionals at the Rothschild Foundation Hospital (ProSeCoV study)
por: Mesnil, Malcie, et al.
Publicado: (2020)

Post-SARS-CoV-2 vaccination specific antibody decrease — Thresholds for determining seroprevalence and seroneutralization differ
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 among blood donors: A practical serosurveillance tool for COVID-19
por: Bansal, N., et al.
Publicado: (2022)

Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital
por: Martyn, Emily M., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls
por: Mathew, Hannah R, et al.
Publicado: (2021)

Seroprevalence of antibodies against SARS-CoV-2 in a large national hospital and affiliated facility in Tokyo, Japan
por: Tanaka, Akihito, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening
por: Pagani, Gabriele, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence in the adult detainees of the Paris area in 2021: A multicenter cross-sectional study
por: Mellon, Guillaume, et al.
Publicado: (2022)

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021
por: Curtis, Stephanie J., et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan
por: Yamamoto, Shohei, et al.
Publicado: (2021)

Does the E gene provide additional information in SARS-CoV-2 PCR?()
por: Zóka, András, et al.
Publicado: (2021)

Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient
por: Pla, Jordi Juanola, et al.
Publicado: (2020)

SARS CoV-2 viral load might not be the right predictor of COVID-19 mortality
por: Kelleni, Mina T.
Publicado: (2021)

Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient
por: Pla, Jordi Juanola, et al.
Publicado: (2020)

High SARS-CoV-2 IgG seroprevalence among pregnant Cameroun women 14 months after the beginning of the pandemic
por: Mansuy, J.-M., et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
por: Petersen, Maria Skaalum, et al.
Publicado: (2020)

RT-PCR tests for SARS-CoV-2 processed at a large Italian Hospital and false-negative results among confirmed COVID-19 cases
por: Valent, Francesca, et al.
Publicado: (2020)

Diagnosing SARS-CoV-2 vaccination-related rhabdomyolysis requires the exclusion of all differential causes
por: Finsterer, Josef, et al.
Publicado: (2023)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence among healthcare workers in a low prevalence region
por: Godbout, Emily J., et al.
Publicado: (2020)

SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis
por: Jones, Christopher R., et al.
Publicado: (2021)

Delivery Care During the SARS-CoV-2 Epidemic in Italy: An Instant Survey
por: Viora, Elsa, et al.
Publicado: (2020)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

SARS-CoV-2 Seroprevalence after Third Wave of Infections, South Africa
por: Kleynhans, Jackie, et al.
Publicado: (2022)

Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)

Ocular motility disorders after SARS-CoV-2 vaccination require the exclusion of all differential causes
por: Finsterer, Josef, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
por: Shakiba, Maryam, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0jlugbjchkga2b04uur60i3l3n